solution

EXPANDING HORIZONS FOR RISK MANAGEMENT IN PHARMA
Risk management has become a top-of-mind issue for C-suites and boards around the world—nowhere more than in
pharmaceutical companies. In a politically and economically turbulent environment, the risks pharma companies face,
especially in clinical-trial design and execution, drug approval, product quality, and global commercial practices, are
increasing in both frequency and magnitude. One obvious sign of the challenging risk environment (among several factors at
work) is the sharp decline in the valuation of specialty companies (35 percent decrease), generic-drug manufacturers (25
percent decrease), and biotech companies (30 percent decrease) over the past two years. Many pharma companies admit
they feel poorly prepared to navigate these choppy waters because their risk analysis and management is not as robust, data
driven, action oriented, or far-reaching as they would wish.
The pharmaceutical industry is unique in several ways, such as the particular clinical challenges it faces in R&D processes,
and the elaborate requirements for market access. However, our experience indicates that these unique characteristics, while
important for risk management, are not the whole story. Several other sectors have much in common with the pharma sector,
and the advanced risk-management practices they adopt can be readily adapted to a pharma context, just as leading riskmanagement
practices in the pharma industry are transferable to other industries. Like energy companies, pharma
companies have high capital expenditure and long payoff periods for assets. Like banks, pharma companies operate in a
highly regulated environment in which compliance risks are very high (for instance, for improper or poor filings) and other
risks (such as sales-conduct risks) are present across many markets globally. Pharma companies also face risks that cut
across sectors, such as cyberthreats, data breaches, supply-chain risks, quality risks, geopolitical exposures, and risks
from third and fourth parties.
With these commonalities in mind, we have identified five risk-management ideas frequently seen in other sectors that can
bring benefits to the pharma industry. These ideas will not only help pharma companies protect themselves against risk but
also enable them to optimize their risk taking—whether to differentiate themselves from competitors or to deepen their
thinking about risk/return trade-offs in management decisions. These include;
Developing a robust quantitative view of which risks matter most
Organize around three lines of defense to strengthen oversight and minimize duplication
Establish your risk appetite and prioritize where to focus
Take advantage of big data and advanced analytics
Form strong crisis-management preparedness
However robust an organization’s risk-management capabilities, they can never rule out the possibility of a crisis event.
Indeed, research has shown that such events have at least doubled—and in some cases more than quadrupled—over the
past ten years across industries. As the threat level increases, so does the need to not only improve core risk capabilities but
also maintain a strong level of crisis preparedness. Being prepared for a crisis includes both obvious elements, such as
ensuring that senior leaders can quickly respond, and less-obvious aspects, such as integrating crisis scenarios into
budgeting and planning. Too often, crisis-management training and preparation revolves around crisis communications,
which is only one part of a much broader challenge. Instead, executives need to plan how the whole company would function
during a crisis. That preparedness planning needs to include considering how the organization and leadership will respond,
how to stabilize stakeholders, and which operational and technical activities will be critical. It should include deciding how
investigation and governance will be conducted; how marketing, brand, and communications teams can help with crisis
management; and what financial and liquidity provisions are in place. Finally, it should include thinking through how legal,
third-party, and other issues will be handled and how ready the whole organization is to cope with any crisis that might
emerge
Case extracted from: Mckinsey and Company https://www.mckinsey.com/business-functions/risk/our-insights/expandinghorizons-
for-risk-management-in-pharma

. ……………………………..

With reference to the pharmaceutical industry, discuss operational risks and provide a detailed report motivating why there is a need for organisations to invest in operational risk management processes.

 
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

solution

Jennifer has been working on a new project to develop a new architectural analytics platform for a large firm. The project team has just finished putting together five user stories for the product. Jennifer needs to take these user stories and place them into sprints. What method would Jennifer use to estimate the difficulty of each user story?

A.

Assign difficulty for each story point based on historical records

B.

Meet with all members of the team and rank the stories based on difficulty then assigned points based on a Fibonacci sequence

C.

Meet with all members of the team and assign each task an estimated number of hours for completion then assign points based on the number of hours

D.

Start with the user story that covers the largest number of users and estimate the number of hours to completion

 
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

solution

The claims processing unit of an auto insurance company receives 40 claims per hour. The claims go through 4 possible stages. See figure below. In each stage, a claim is handled by only one worker. All claims first go through a Review stage, staffed by 4 workers. A worker at the Review stage takes 6 minutes to process a claim. After the Review stage, all claims go through an Evaluation and Verification stage, staffed by 6 workers. A worker in this stage takes 10 minutes per claim. After the Evaluation and Verification stage, on average, only 25% of claims turn out to be ‘clean’ that can be directly authorized for payment. The remaining 75% of claims require a further Management Review for handling exceptions. There are 6 workers at the Management Review stage, and it takes 15 minutes for a worker to perform a management review per claim. After the Management Review, only 60% of the claims are approved and authorized for payment. The remaining 40% of the claims are rejected and exit the system. There are two workers at the Authorization for Payment stage who issue payment for approved claims, and it takes a worker 5 minutes per claim.

The claims processing unit of an auto insurance company receives 40 claims per hour. The claims go...-1

Data on each stage is provided in the following table:The claims processing unit of an auto insurance company receives 40 claims per hour. The claims go...-2

A)

What is the implied utilization at the ‘Authorization for Payment’ stage? Choose the numerically closest answer. Recall that the system receives 40 claims per hour.

45%

85%

105%

115%

135%

155%

185%

200%

B)

What is the “entry” capacity of the entire system in claims per hour, i.e., the maximum number of claims per hour that the system can receive and process”? Choose the numerically closest answer.

10

20

30

40

50

60

70

80

90

C)

Suppose a worker at the ‘Authorization for Payment’ stage takes 4 mins for a claim that is received directly from the ‘Evaluation and Verification’ stage but takes 10 mins per claim that is received from the ‘Management Review’ stage. What is the implied utilization at the ‘Authorization for Payment’ stage? Assume as before that there are 2 workers at this stage and that the system receives 40 claims per hour. Choose the numerically closest answer.

40%

80%

100%

120%

140%

160%

180%

200%

 
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"

solution

Pulin Kayastha was simply amazed. He had seen all forms of hostility and marketing warfare in the consumer goods industry, but to see similar warfare in the health industry baffled him. Clearly, he told himself, doctors had found consumers in their patients. At least, that’s what the concept note sent by Dr. Ajit Varman, country manager of Healing Home Clinics & Hospitals, seemed to indicate. Varman and seven other senior doctors had left Karuna Nursing Home and Hospital to set up Healing Home, which, as the note said, “…. would be entirely devoted and dedicated to customer service.”

Pulin was a management consultant and was recommended to Healing Home by the marketing director of Regrow Pharma, a large pharmaceuticals company in Mumbai. In fact, the suggestion to set up Healing Home came from a non-resident patient, Dinesh Shah, who was undergoing treatment at Karuna’s large speciality hospital in Central India. It was in the course of his interaction with the doctors that Shah sensed their unhappiness with the system. This prompted him to suggest the idea of Healing Home. Varman had joined Karuna 10 years ago, assured of a challenging career in a hospital that was promising to be different. But over time, disillusionment set in as Karuna’s image and response to the environment diluted its equity.

“Now that we have decided to do this, we do not want to repeat old mistakes,” Varman had told Pulin during their first meeting. “Having worked at Karuna, we can see its weaknesses and why it’s losing saliency. Ten years ago, when it was established, we believed it was going to add value to our careers. We became a part of it because we were told that we are specialists who would bring exclusivity to the hospital. But soon, the focus shifted to fetching business and revenues. The management started hiring specialists and private practitioners, offering them cabins and consultancy arrangements at Karuna. The strategy was that these doctors would bring in their patients and use the infrastructure so that the hospital would start earning money.”

The Karuna management wanted to derive short-tem benefits, than gradually build up clientele. But the strategy, it appeared, did not pay off. As Varman said: “Because there were many doctors and the business was not large enough in the first few months. Consequently, competition for business became cutthroat between doctors.

Despite a nice outlook they did not have any modern machines which disappointed the patients. The image of the hospital was that of being too commercial – a fallout of the stigma of being a private hospital. It was common among doctors to slot every hospital under either category – a place where you get neglected to death or a place where you get researched to death. Karuna earned a new label – a place where you got cross-referred to death, for doctors at Karuna slowly took to enhancing each others earnings as they sent patients back and forth to doctors and specialists. At the end of his diagnoses, the patient ended up paying a huge amount of money for this treatment.

According to Varman, the high-cost, high-expectation syndrome hit the hospital. The initial promise of exclusivity and quality was lost. Karuna had the best doctors, but after-care was abysmal. With a view to keeping costs low, nurses, housekeeping staff and even the front office staff were hired cheap, training was virtually absent, and no attention was paid to end user needs.

Kayastha could see Healing Home trying to be all that Karuna was not and desiring not to be all that Karuna was. If Kayastha thought Varman was hiring him for routine systems design and a patient management manual, he was mistaken. For Varman said “We want to get Healing Home’s positioning platform right and work on a sound marketing plan. What we want you to do is to help us build this brand, help ordinary doctors like us understand what brand-building entails and how it is managed in a service industry.”

According to the case–

(a) Suggest a positioning strategy for Recovery Clinics and Hospitals. (300 words)

(b) Explain why it would be necessary for doctors as well as nursing staff to be marketing oriented. (300 words)

if you can’t follow my requirements then don’t waste my questions please. these answers should be 300 words individually. Read the case carefully then answer these questions.


 
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"